Recalls / Active ingredient / Dobutamine Hydrochloride
Dobutamine Hydrochloride
3 FDA drug recalls involving the active ingredient “Dobutamine Hydrochloride” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-05-28 | Class II | DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, | Pfizer Inc. |
| 2014-01-10 | Class I | DOBUTamine Injection, USP, 250 mg per 20 mL, 20 mL Single-dose Fliptop Vial, Rx only, Manufactured for Hospira | Hospira Inc. |
| 2013-04-30 | Class II | DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FO | Hospira Inc. |